During the past decade, National Heart Foundation Hospital & Research Institute conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Heart Foundation Hospital & Research Institute" #1 sponsor was "Medtronic Cardiac Rhythm and Heart Failure" with 2 trials, followed by "Concept Medical Inc." with 1 trials sponsored, "Mark Eisenberg" with 1 trials sponsored, "Medtronic Cardiac Surgery" with 1 trials sponsored and "National Heart Foundation of Bangladesh" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Heart Foundation Hospital & Research Institute" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Heart and Stroke Foundation of Canada" with 1 trials as a collaborator, "Johns Hopkins University" with 1 trials as a collaborator, "National Heart Foundation Hospital and Research Institute of Bangladesh" with 1 trials as a collaborator and "Resolve to Save Lives, USA." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "National Heart Foundation Hospital & Research Institute" are "Acute Coronary Syndrome" (2 trials), "Coronary Artery Disease" (2 trials), "Acute Myocardial Infarction" (1 trials), "Diabetes" (1 trials) and "Hypertension" (1 trials). Many other conditions were trialed in "National Heart Foundation Hospital & Research Institute" in a lesser frequency.

Most popular intervention types in "National Heart Foundation Hospital & Research Institute" are "Behavioral" (2 trials), "Device" (2 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Abluminus DES+ Sirolimus Eluting Stent System (SES)" (1 trials), "Bupropion HCl ER" (1 trials), "EP referred group" (1 trials), "Evidence based guidelines and tools" (1 trials) and "Fixed Dose Combination pill of Telmisartan 40mg and Amlodipine 5 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Heart Foundation Hospital & Research Institute" are 7 trials for "All" genders.

Currently, there are NaN active trials in "National Heart Foundation Hospital & Research Institute". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in National Heart Foundation Hospital & Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Heart Foundation Hospital & Research Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".